Rising prevalence of HIV, infectious disease, and
others has led to increasing demand for bioanalytical testing services globally.
Moreover, increasing government initiatives to control the outbreak of various
infectious diseases such as Corona and Ebola virus is anticipated to offer more
opportunities for the market. Hence, the market is expected to grow over the
assessment period.
The market is expected to witness lucrative growth
during the forecast period due to increased research activities and the
presence of a huge pipeline of peptides, biologics, and amino acids based
molecules. Additionally, bioanalysis of large molecules requires skilled
professionals with innovative analytical instruments and infrastructure. These
services are readily offered by bioanalytical testing service providers and are
likely to propel the growth of the market during the assessment period.
North America accounted for the highest share in 2019.
The U.S. holds the highest market share due to the increasing prevalence of
various chronic diseases and the growing adoption of large molecule
therapeutics as an alternative for small molecules.
For example, according to International Diabetes
Federation Report 2019, around 49.0 million geriatric population in the U.S.
has diabetes and this has led to increasing requests for bioanalysis of the
novel (large molecule compounds) peptide therapeutics such as glucagon-like
peptide 1(GLP-1). Due to this reason, the market is expected to show growth
over the forecast period. In addition, the presence of major players in the
region contributed to market growth.
Related Press Release@ Large Molecule Bioanalytical Testing Service Market Report
Large Molecule Bioanalytical
Testing Services Market Report Highlights
- By type, the clinical segment held the largest market share in 2019
owing to increasing demand for clinical trials due to the rising
prevalence of various infectious diseases
- Bioavailability held the largest market share of 20.9% in 2019
owing to increasing adoption in generic drug manufacturing
- The oncology segment held the largest revenue share due to the
increasing prevalence of cancer globally
- The U.S. is expected to witness the fastest growth over the
forecast period owing to the growing adoption of advanced therapeutic
techniques in the country.
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment